"India's pharmaceutical exports continued its lead over China in 2015...India maintains its supremacy over China in pharmaceuticals," the ministry said in a statement.
While India's pharma exports grew from $11.66 billion to $12.54 billion in 2015, recording a growth of 7.55%, China's exports rose by 5.3% to $6.94 billion, it added.
Also Read
India's exports of pharma products to the US jumped by 23.4% to $4.74 billion last year.
On the other hand, China's pharma exports to the US increased by 15% to $1.34 billion in the same period.
"India also maintained its lead with growth in EU and Africa recording exports of $1.5 billion and $3.04 billion respectively, while China's exports to EU and Africa showed a declining trend in both the markets," the statement said.
India is hugely dependent on China for import of APIs, which are the raw materials for medicines.
Industry and government have time and again raised concerns over increasing dependence on imported APIs from China.
India is a global hub of generic medicines. The market size of the country's pharma industry is estimated at over $20 billion.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)